OALib Journal期刊
ISSN: 2333-9721
费用:99美元
|
|
|
lc-ms/ms法同时测定犬全血中丁酸氯维地平及其代谢物氯维地平酸
, PP. 1290-1296
Keywords: 丁酸氯维地平,氯维地平酸,药代动力学,lc-ms/ms
Abstract:
本文建立了一种快速、灵敏、简便的可同时测定beagle犬全血中丁酸氯维地平及其代谢产物氯维地平酸的液相色谱-串联质谱方法。全血样品经甲醇沉淀蛋白后,以甲醇-5mmol·l-1甲酸铵水溶液为流动相,通过ecosilc18(150mm×4.6mm,5μm)梯度洗脱,色谱运行时间为13.0min。质谱检测条件为电喷雾离子源多反应监测模式,定量离子对为m/z454.1[m-h]-→234.1(丁酸氯维地平),m/z354.0[m-h]-→208.0(氯维地平酸),m/z256.1[m-h]-→227.1(乙氧苯柳胺,内标)。测定beagle犬全血中丁酸氯维地平及其代谢物的标准曲线线性范围分别为0.5~100和1~200ng·ml-1,定量下限分别为0.5和1ng·ml-1,日内和日间精密度(rsd)均小于12.9%。应用建立的定量方法成功地研究了beagle犬静脉输注(5mg·h-1)丁酸氯维地平注射液30min后药动学特征。
References
[1] | ericssonh,tholanderb,björkmanja,etal.pharmacokineticsofnewcalciumchannelantagonistclevidipineintherat,rabbit,anddogandpharmacokinetic/pharmacodynamicrelationshipinanesthetizeddogs[j].drugmetabdispos,1999,27:558-564.
|
[2] | faktc,stenhoffh.determinationofanultrashort-actingantihypertensivedihydropyridine,clevidipine,inbloodusingcapillarygaschromatography-massspectrometryandoftheprimarymetaboliteusingliquidchromatographyandfluorescencedetection[j].jchromatogrbbiomedsciappl,1999,723:211-219.
|
[3] | peacockwf,angelesje,sotokm,etal.parenteralclevidipinefortheacutecontrolofbloodpressureinthecriticallyillpatient:areview[j].therclinriskmanag,2009,5:627-634.
|
[4] | ericssonh,bredbergu,erikssonu,etal.pharmacokineticsandarteriovenousdifferencesinclevidipineconcentrationfollowingashort-andalong-termintravenousinfusioninhealthyvolunteers[j].anesthesiology,2000,92:993-1001.
|
[5] | feldsteinc.managementofhypertensivecrises[j].amjther,2007,14:135-139.
|
[6] | varonj,marikpe.clinicalreview:themanagementofhypertensivecrises[j].critcare,2003,7:374-384.
|
[7] | nordlanderm,sjoquistpo,ericssonh,etal.pharmacodynamic,pharmacokineticandclinicaleffectsofclevidipine,anultrashort-actingcalciumantagonistforrapidbloodpressurecontrol[j].cardiovascdrugrev,2004,22:227-250.
|
[8] | singlan,warltierdc,gandhisd,etal.treatmentofacutepostoperativehypertensionincardiacsurgerypatients:anefficacystudyofclevidipineassessingitspostoperativeantihypertensiveeffectincardiacsurgery-2(escape-2),arandomized,double-blind,placebo-controlledtrial[j].anesthanalg,2008,107:59-67.
|
[9] | zhangjg,dehalss,johnsonj,etal.humancytochromep450inductionandinhibitionpotentialofclevidipineanditsprimarymetaboliteh152/81[j].drugmetabdispos,2006,34:734-737.
|
[10] | zhouy,lih,hex,etal.simultaneousdeterminationofclevidipineanditsprimarymetaboliteindogplasmabyliquidchromatography-tandemmassspectrometry:applicationtopharmacokineticstudy[j].jpharmbiomedanal,2014,100:294-299.
|
[11] | fda.guidanceforindustry:bioanalyticalmethodvalidation[eb/ol].http://www.fda.gov/downloads/drugs/guidencecomplianceregulatoryinformation/guidances/ucm070107.pdf2001-05.
|
[12] | lihz.biopharmaceuticalanalysis(体内药物分析)[m].beijing:people'smedicalpublishinghouse,2008:52.
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|